关于氯喹/羟氯喹治疗 2019 年冠状病毒病（COVID-19）的最新情况。
Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
机构信息
Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, China.
Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, China.
出版信息
Biosci Trends. 2020 May 21;14(2):156-158. doi: 10.5582/bst.2020.03072. Epub 2020 Apr 13.
Drugs that are specifically efficacious against SARS-CoV-2 have yet to be established. Chloroquine and hydroxychloroquine have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). Increasing evidence obtained from completed clinical studies indicates the prospects for chloroquine/hydroxychloroquine to treat COVID-19. More randomized control clinical studies are warranted to determine the feasibility of these two drugs in treating COVID-19.
目前尚未发现针对 SARS-CoV-2 具有特效的药物。氯喹和羟氯喹因其治疗 2019 年冠状病毒病（COVID-19）的潜力而备受关注。越来越多的临床研究结果表明氯喹/羟氯喹治疗 COVID-19 的前景。需要更多的随机对照临床研究来确定这两种药物治疗 COVID-19 的可行性。
Zotero 插件